. Ishikura Y, et al. Cell Stem Cell. 2021 Sep 1:S1934-5909(21)00342-8. doi: 10.1016/j.stem.2021.08.005. Online ahead of print. Cell Stem Cell. 2021. PMID: 34496297
.
.
. Markmiller S, et al. Cell Rep. 2021 Sep 7;36(10):109685. doi: 10.1016/j.celrep.2021.109685. Cell Rep. 2021. PMID: 34496257
.
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
- Gluten intolerance a significant risk factor
- Infectious disease of the uterus
- Absence of an individual specific disease